文献速递肺结节与肺癌

美国2015-2020年肺癌治疗模式与差异

Patterns and Differences in Lung Cancer Treatment: United States, 2015-2020.
PubMed 文献 · Chest · 2024-10-26

基于覆盖美国89%人口的2015-2020年国家癌症登记数据,纳入1,068,155例≥20岁肺癌患者,描述首次治疗并分析社会人口学差异。结果显示22%接受手术、41%化疗、40%放疗、13%免疫治疗,75%接受至少一种治疗;高龄、某些种族/族裔、非都市县、低经济水平县及西部 census 区域的患者接受治疗 odds 显著更低。

要点

  • 化疗和放疗是最常见的首次治疗方式,分别占41%和40%。
  • 75%的患者接受了至少一种四种治疗,但不同社会人口学特征间差异显著。
  • 高龄、美国印第安/阿拉斯加原住民、黑人、西班牙裔、非都市县及低经济水平县居民治疗 odds 更低。

核心结论

  • 肺癌首次治疗以化疗和放疗最常见,但接受至少一种治疗的比例在多个社会人口学群体中较低。

研究设计与样本

  • 基于2015-2020年美国国家癌症登记项目数据(覆盖89%人口)的回顾性研究,纳入1,068,155例≥20岁肺癌患者,采用多因素logistic回归分析社会人口学特征与治疗接受的关系。

主要发现

  • 在1,068,155例肺癌患者中,22%接受手术,41%接受化疗,40%接受放疗,13%接受免疫治疗,75%接受至少一种四种治疗。
  • 年龄≥45岁(OR范围0.08-0.67)、美国印第安/阿拉斯加原住民(OR 0.82,95%CI 0.77-0.87)、黑人(OR 0.82,95%CI 0.81-0.84)、西班牙裔(OR 0.80,95%CI 0.78-0.82)接受至少一种治疗的 odds 显著更低。
  • 居住于非都市县(OR 0.98,95%CI 0.96-0.99)、经济水平最低25%县(OR 0.80,95%CI 0.78-0.81)和中间50%县(OR 0.87,95%CI 0.86-0.88)、美国西部 census 区域(OR 0.95,95%CI 0.94-0.97)的患者接受至少一种治疗的 odds 也显著更低。

临床怎么用

  • 临床医生应关注高龄、少数族裔、低经济水平地区及非都市县肺癌患者,评估其治疗接受差异并针对性干预。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment for lung cancer can improve prognosis, but 5-year survival remains low at 26%. An examination of treatment using data with higher population coverage, and among a broader number of treatment modalities and individual characteristics, would provide greater insight into differences in lung cancer treatment. RESEARCH QUESTION: Among adults diagnosed with lung cancer, how does reported receipt of lung cancer treatment differ by sociodemographic characteristics? STUDY DESIGN AND METHODS: We used 2015-2020 National Program of Cancer Registry data covering 89% of the US population to describe first-course treatment among people aged ≥ 20 years and diagnosed with lung and bronchus cancer. We performed multivariable logistic regression to examine associations between sociodemographic characteristics and treatment received. RESULTS: Among 1,068,155 people diagnosed with lung cancer, 22% received surgery, 41% received chemotherapy, 40% received radiation, 13% received immunotherapy, and 75% received at least one of the four treatments. People who were aged ≥ 45 years (OR range, 0.08-0.67); were of American Indian or Alaska Native (OR, 0.82; 95% CI, 0.77-0.87), Black (OR, 0.82; 95% CI, 0.81-0.84), or Hispanic (OR, 0.80; 95% CI, 0.78-0.82) race/ethnicity; resided in a nonmetropolitan county (OR, 0.98; 0.96-0.99); resided in the bottom 25% (OR, 0.80; 95% CI, 0.78-0.81) and middle 50% (OR, 0.87; 95% CI, 0.86-0.88) of counties by economic status (considers unemployment rate, per capita market income, and poverty rate); and in the West US census region (OR, 0.95; 95% CI, 0.94-0.97) had significantly lower odds of receiving at least 1 of the 4 treatments. INTERPRETATION: Chemotherapy and radiation were the most common types of first-course treatment reported. Receipt of at least one of the four treatments examined was lower among several groups, including certain racial and ethnic groups and those residing in counties with lower economic status. Future studies might further identify and intervene on factors underlying differences.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Kava CM, Siegel DA, Qin J, et al. Patterns and Differences in Lung Cancer Treatment: United States, 2015-2020. Chest. 2024. PMID: 39490974. doi:10.1016/j.chest.2024.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。